qsi stock: Quantum‑Si (QSI) overview
Quantum‑Si Incorporated (QSI)
qsi stock refers to the Class A common shares of Quantum‑Si Incorporated, listed on the Nasdaq under the ticker QSI. This article explains what qsi stock is, the company’s business in next‑generation protein sequencing and proteomics, key corporate milestones, where to find trading data and filings, common investor considerations and risks, and practical guidance on following or trading QSI (including using Bitget’s services). The guide is aimed at beginners and intermediate investors who want reliable, source‑based information about qsi stock and how it fits into the broader multiomics and biotech technology theme.
Company overview
Quantum‑Si is a life‑sciences technology company focused on developing a next‑generation protein sequencing platform intended to enable scalable, high‑resolution proteomics. The company’s product strategy centers on an integrated system of instruments, consumables and software designed to read protein information at high throughput. Quantum‑Si’s technology and business model aim to serve research institutions, biotech and pharmaceutical companies, and other organizations working in proteomics and multiomics workflows.
Key facts (summary):
- Public ticker: QSI (Nasdaq)
- Security type: Class A common stock (equity)
- Industry focus: Proteomics / next‑generation protein sequencing (NGPS)
- Offerings: Instruments, consumables, software and services for proteomics
This article treats qsi stock as an equity security on U.S. markets, not a cryptocurrency or token. Readers will find where to obtain market quotes, filings and company disclosures, plus an overview of risks and market sentiment around qsi stock.
History and corporate development
This section summarizes major public milestones and the evolution of the company and its sequencing platform. It is a concise chronology highlighting founding and important corporate events relevant to qsi stock holders and prospective followers.
Founding and technology development
Quantum‑Si was founded to commercialize a next‑generation protein sequencing approach that aims to read proteins at single‑molecule resolution. Over multiple development stages the company moved from research prototypes toward a commercial‑grade platform composed of instruments, chemistry/consumables, and software analytics. The technology roadmap has included technical demonstrations, internal validation, instrument pilots with early customers, and steps toward broader commercialization.
Quantum‑Si’s R&D and engineering milestones typically involve improvements in throughput, accuracy, sample preparation workflows and software to translate raw signals into actionable proteomics data. These technical milestones are material events for holders of qsi stock because they can affect product adoption timelines, revenue visibility and investor sentiment.
Public listing and corporate actions
Quantum‑Si completed its public listing and trades on the Nasdaq under the ticker QSI. Since listing, the company has engaged in common corporate actions for growth‑stage life sciences companies, including capital raises (secondary offerings or at‑the‑market equity programs), investor presentations and analyst events to communicate progress on product commercialization and financial results. Material announcements—such as new product releases, partnerships, or major positive/negative technical results—can produce significant price and volume moves in qsi stock.
For up‑to‑date official record of such corporate events, investors should consult Quantum‑Si’s investor relations disclosures and SEC filings.
Business model and products
Quantum‑Si’s revenue model mirrors that of many life‑sciences platform companies: hardware instrument sales, recurring consumables and reagents, software and analytics services, and professional services such as training and installation. The long‑term commercial thesis centers on attaching recurring consumables and software revenue to a growing installed base of instruments.
Typical revenue drivers for companies like Quantum‑Si include:
- Instrument sales: one‑time hardware purchases for labs and centers.
- Consumables and reagents: recurring product sales required to run assays on the instruments.
- Software and analytics subscriptions or licenses: cloud or on‑premise analytical tools that convert raw sequencing data into usable insights.
- Services and support: training, maintenance and professional services around deployment and assay development.
Target markets include academic research labs, pharmaceutical and biotech companies pursuing biomarker discovery or drug development, clinical research organizations and companies working in multiomics workflows. The company’s ability to convert instrument placements into recurring consumable and software revenue is a central metric for assessing commercial traction.
Stock information
This section provides the essential public identifiers and where to find live market data for qsi stock.
- Ticker symbol: QSI
- Exchange: Nasdaq
- Share class: Class A common stock
- Security type: Equity (common shares)
- Primary quote sources: Nasdaq market pages, TradingView, financial market data platforms, and the company’s investor relations stock quote and chart tool
Investors should note that qsi stock is a U.S.‑listed equity and standard brokerage accounts that provide access to Nasdaq equities can trade QSI shares. For non‑U.S. investors, international brokerages and platforms that support U.S. equity access may be used—Bitget provides U.S. equities trading access and tools to follow quotes and place orders.
Trading data and market statistics
When monitoring qsi stock, common market statistics and data points investors track include:
- Market capitalization: total equity market value (shares outstanding × share price).
- Shares outstanding and float: to assess dilution risk and potential supply effects.
- 52‑week high and low: historical price range used to contextualize current price.
- Average daily trading volume: liquidity metric.
- Intraday trading range and pre‑market/after‑hours activity: relevant for news‑driven moves.
- Short interest and institutional holdings: sentiment indicators.
Reliable sources for these metrics include the company’s investor relations pages, Nasdaq market data, TradingView and other financial data providers. For SEC‑verified statistics like shares outstanding, the company’s most recent 10‑Q or 10‑K filings are authoritative.
Historical price performance
qsi stock has exhibited volatility typical of small‑cap life‑science and technology companies, particularly those transitioning from R&D to commercialization. Historical volatility spikes have often aligned with: earnings releases, product announcements, pilot or commercial deployment news, capital raises, and analyst or media coverage.
As an example for context (date‑bound): As of January 22, 2026, a market snapshot reported QSI trading near $1.21 per share. Readers should treat that as a dated illustration rather than a real‑time price and consult live markets for current quotes.
Financials and operating results
Public financial statements for Quantum‑Si provide the standard consolidated financials: revenue, gross margin, operating expenses (R&D and SG&A), operating income or loss, net income or loss, EPS and balance sheet items like cash and debt. For many emerging life‑sciences platform companies, recurring themes include:
- Early‑stage revenue scale with potentially meaningful operating losses as R&D and commercialization expenses are incurred.
- Capital deployment aimed at product development, validation and growing the commercial organization.
- Cash runway and financing needs: equity raises or other capital strategies can be material events affecting qsi stock.
Investors seeking precise, up‑to‑date financial metrics should consult the company’s quarterly (10‑Q) and annual (10‑K) SEC filings and investor presentations for management’s discussion and analysis and the audited statements.
Analysts, ratings and market sentiment
qsi stock receives varying levels of analyst attention and retail investor interest. Sources of coverage include sell‑side analysts, independent equity research, and retail sentiment platforms.
- Institutional analysts and sell‑side coverage: some analysts covering multiomics and genomics themes may provide models, ratings and price targets for QSI. Consensus ratings and price target aggregates can be found on mainstream market data platforms and through broker research subscriptions.
- Retail sentiment and social platforms: qsi stock is discussed on community platforms such as Stocktwits and TradingView, where user ideas and commentary can shape short‑term sentiment.
- Forecast tools and community polls: platforms like Public.com and others host community forecasts and price‑target discussions for qsi stock.
Notably, thematic research from major investment firms can influence interest in qsi stock. As of January 22, 2026, ARK Invest’s Big Ideas 2026 report (reported by market news outlets) listed Quantum‑Si among suggested stocks tied to the “Multiomics” theme. This inclusion highlights that some thematic investors consider Quantum‑Si a potential exposure to multiomics innovation, though such mentions are thematic and not investment advice. Readers should note the date and source: "As of January 22, 2026, according to ARK Invest’s Big Ideas 2026 report (reported by Benzinga)."
When reviewing analyst commentary about qsi stock, remember that ratings and price targets are opinions and vary between providers. Always check the publication date and the underlying assumptions.
Regulatory filings and investor relations
For authoritative disclosures about business operations, financials and material events related to qsi stock, consult:
- SEC filings (Form 10‑K, 10‑Q, 8‑K, proxy statements): provide audited financials, risk factors and material event notices.
- Company investor relations materials: quarterly results, investor presentations, press releases and stock quote tools maintained by the company.
Quantum‑Si’s investor relations page maintains a stock quote and chart tool as well as press releases and filings that are useful for tracking developments that impact qsi stock. Investors should prioritize primary documents (SEC filings and company press releases) for verified information.
Risk factors and considerations
Investing in qsi stock carries risks that are common to small‑cap, technology‑driven life‑sciences companies. Key risk areas include:
- Early commercial adoption risk: the company’s revenue outlook depends on adoption of a new platform in proteomics, which can take time.
- Technical and execution risk: the ability to develop, manufacture and deliver instruments and consumables at required performance levels and cost is central to commercial success.
- Operating losses and financing/dilution risk: many companies in this stage operate at a net loss while scaling and may issue additional equity or take other financing measures that dilute existing holders.
- Competitive risk: established players and new entrants in sequencing and proteomics can pressure market share and pricing.
- Regulatory and compliance risk: while proteomics research tools may not face the same regulatory pathways as diagnostics or therapeutics, any clinical claims or diagnostic uses can trigger additional regulatory scrutiny.
- Market volatility: qsi stock has historically shown price swings around news events and broader biotech/market moves.
These risk factors are common themes described in the company’s risk disclosures in SEC filings. Readers should consult the latest 10‑K and 10‑Q for a complete, up‑to‑date list of risks related to qsi stock.
Trading and market access
How to follow and trade qsi stock:
- Brokerage access: qsi stock trades on Nasdaq, so any brokerage that provides U.S. equity trading can place orders in QSI shares. For traders seeking a consolidated platform, Bitget offers U.S. equity trading services and market data tools to watch qsi stock and place trades.
- Pre‑market and after‑hours: Nasdaq‑listed stocks can trade in pre‑market and after‑hours sessions. Volume and spreads may differ outside regular market hours, increasing volatility and execution risk for qsi stock.
- Data providers and real‑time quotes: market participants commonly use Nasdaq, TradingView, financial data terminals and the company’s investor relations quote tool for near‑real‑time pricing and charts for qsi stock.
- Social and community signals: platforms such as Stocktwits and TradingView community ideas can give a sense of retail sentiment for qsi stock, but these are informal and should be taken with caution.
If you plan to trade, ensure your brokerage supports U.S. equities, check order types and extended‑hours trading rules, and be mindful of liquidity and transaction costs when trading qsi stock. Bitget’s interface includes price alerts, charts, and order‑type options that help manage those considerations.
See also
- Proteomics
- Next‑generation sequencing (NGS) and multiomics
- Publicly traded companies in proteomics and genomics
References
(Primary sources consulted for this article — search for these sections on the named sites for the latest updates.)
- Quantum‑Si investor relations: stock quote & chart and press releases
- Nasdaq market activity pages and advanced charting for QSI
- TradingView company profile for QSI
- Stocktwits QSI feed and community posts
- Public.com QSI forecast and price‑target discussions
- Financial market content providers and market news aggregators for price snapshots
- ARK Invest, "Big Ideas 2026" thematic report (as reported by market outlets). As of January 22, 2026, ARK’s report included Quantum‑Si among stocks referenced for the Multiomics theme (reported by Benzinga).
External links and where to follow qsi stock (key pages to search)
- Quantum‑Si investor relations (stock quote & chart tool)
- Nasdaq QSI quote and market activity pages
- TradingView QSI profile and charts
- Stocktwits QSI feed
- Public.com QSI forecast page
Please search for the above pages by name to access the company’s primary disclosures and real‑time market pages. Avoid relying solely on third‑party summaries—primary filings and company IR updates are the authoritative sources for material events.
Further exploration and next steps
If you want to monitor qsi stock closely:
- Add QSI to a watchlist on your trading platform and enable price alerts.
- Subscribe to Quantum‑Si investor relations email alerts for earnings releases and material announcements.
- Review the company’s most recent SEC filings for the latest financials and risk disclosures.
- Follow thematic research (for example, multiomics coverage) from credible research providers for broader context.
For traders and investors seeking a trading platform and tools, Bitget provides U.S. equities trading access, charting, alerts and an integrated wallet service for digital asset needs. Explore Bitget’s market data and order tools to follow qsi stock and other equities in one place.
More practical resources and an ongoing news feed can help you stay informed about qsi stock developments and the broader proteomics theme.
(End of article.)
